Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
phosphate de clindamycine |
Is a |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin palmitate hydrochloride |
Is a |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin hydrochloride |
Is a |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin measurement (procedure) |
Component |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin adverse reaction |
Causative agent (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin allergy |
Causative agent (attribute) |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin 1% roll-on lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin 1% topical alcoholic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Parenteral clindamycin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Topical clindamycin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin 75mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin 10mg/mL gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 150mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 600mg/4mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 300mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 150mg/mL injection solution 6mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 10mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 600mg/bag solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 300mg/50mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 900mg/50mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 2% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 300mg/50mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 600mg/50mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 900mg/50mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 100mg vaginal ovule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 10mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 150mg/mL injection solution 4mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cleocin t 10mg/ml lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 150mg/ml injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin 1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamylin phosphate 900mg/6ml injection solution 6mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin 2% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 150mg/mL injection solution 4 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 2% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 20 mg/mL vaginal cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin hydrochloride 75mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin hydrochloride 150mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin 600mg/4mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin 1% topical foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide- and clindamycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin-containing product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin- and tretinoin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzoyl peroxide 2.5% + clindamycin 1.2% topical gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin 1.2%/tretinoin 0.025% topical gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin allergy |
Causative agent (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin hydrochloride) 75 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 100 milligram/1 each conventional release vaginal pessary (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin hydrochloride |
Is modification of (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin palmitate hydrochloride |
Is modification of (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
phosphate de clindamycine |
Is modification of (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 300 milligram/2 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 600 milligram/4 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing clindamycin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzoyl peroxide- and clindamycin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin and tretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzoyl peroxide and clindamycin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only clindamycin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin only product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzoyl peroxide and clindamycin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin and tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin- and tretinoin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin hydrochloride) 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 20 milligram/1 gram conventional release vaginal cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin (as clindamycin phosphate) 10 mg/g and tretinoin 250 microgram/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 6 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin (as clindamycin phosphate) 150 mg/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous emulsion |
Has basis of strength substance (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |